The global meningococcal vaccine market size was USD 3.10 Billion in 2022 and is expected to register a revenue CAGR of 5.9% during the forecast period. Increasing prevalence of meningitis and rising investment in new vaccine development are key factors driving the market revenue growth. Additionally, technological advancement in the field is another factor contributing to market revenue...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Russian
Romaian